These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 6299184)

  • 1. Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis.
    Latif R; Dajani AS
    Antimicrob Agents Chemother; 1983 Jan; 23(1):46-8. PubMed ID: 6299184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.
    Del Rio M; McCracken GH; Nelson JD; Chrane D; Shelton S
    Antimicrob Agents Chemother; 1982 Oct; 22(4):622-7. PubMed ID: 6295262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.
    Goldwater PN
    Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefotaxime diffusion into cerebrospinal fluid of children with meningitis.
    Asmar BI; Thirumoorthi MC; Buckley JA; Kobos DM; Dajani AS
    Antimicrob Agents Chemother; 1985 Jul; 28(1):138-40. PubMed ID: 4037772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children.
    Barson WJ; Miller MA; Brady MT; Powell DA
    Pediatr Infect Dis; 1985; 4(4):362-8. PubMed ID: 3895175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
    Reed MD; Rekate HL; Aronoff SC; Myers CM; Blumer JL
    Clin Pharm; 1983; 2(6):558-63. PubMed ID: 6317277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.
    Steele RW; Eyre LB; Bradsher RW; Weinfeld RE; Patel IH; Spicehandler J
    Antimicrob Agents Chemother; 1983 Feb; 23(2):191-4. PubMed ID: 6301362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MICs and MBCs of cefotaxime, desacetylcefotaxime and ceftriaxone against four principal bacteria causing meningitis].
    Deguchi K; Fukuyama S; Nishimura Y; Nishike A; Fukumoto T; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N
    Jpn J Antibiot; 1984 Sep; 37(9):1701-13. PubMed ID: 6096585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion of ceftriaxone into the cerebrospinal fluid of adults.
    Chandrasekar PH; Rolston KV; Smith BR; LeFrock JL
    J Antimicrob Chemother; 1984 Oct; 14(4):427-30. PubMed ID: 6094424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ceftriaxone with standard therapy for bacterial meningitis.
    Steele RW; Bradsher RW
    J Pediatr; 1983 Jul; 103(1):138-41. PubMed ID: 6306192
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis.
    Martin E; Koup JR; Paravicini U; Stoeckel K
    J Pediatr; 1984 Sep; 105(3):475-81. PubMed ID: 6088747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.
    Nahata MC; Durrell DE; Barson WJ
    Chemotherapy; 1986; 32(2):89-94. PubMed ID: 3698727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ceftriaxone and traditional therapy of bacterial meningitis.
    Congeni BL
    Antimicrob Agents Chemother; 1984 Jan; 25(1):40-4. PubMed ID: 6322681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis.
    Thirumoorthi MC; Buckley JA; Aravind MK; Kauffman RE; Dajani AS
    J Pediatr; 1981 Dec; 99(6):975-9. PubMed ID: 6458673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebrospinal fluid diffusion kinetics of cefotaxime and fosfomycin in Staphylococcus aureus meningitis with otorrhea].
    Tremeaux JC; Portier H; Sautreaux JL; Pechinot A; Kazmierczak A
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):556-8. PubMed ID: 6087251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fundamental and clinical evaluation of ceftriaxone in the pediatric field].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1984 Nov; 37(11):2111-30. PubMed ID: 6098705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and pharmacokinetic study of ceftriaxone in pediatric bacterial infections].
    Meguro H; Nonaka C; Kawaoi T; Takahashi S; Fujii R; Arimasu O
    Jpn J Antibiot; 1984 Nov; 37(11):2049-59. PubMed ID: 6098701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily administration of ceftriaxone in the treatment of meningitis and other serious infections in children.
    Martin E
    Eur J Clin Microbiol; 1983 Oct; 2(5):509-15. PubMed ID: 6315428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic concentrations in liquor compared to the minimal inhibitory concentrations of isolates in paediatric bacterial meningitis. The Finnish Study Group.
    Ellmén JK; Renkonen OV; Anttila MA; Peltola HO
    Chemotherapy; 1991; 37(1):1-5. PubMed ID: 1901543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of bacterial meningitis with ceftizoxime.
    Overturf GD; Cable DC; Forthal DN; Shikuma C
    Antimicrob Agents Chemother; 1984 Feb; 25(2):258-62. PubMed ID: 6324670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.